175 related articles for article (PubMed ID: 8989252)
21. Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men.
Hoffstedt J; Arner P; Hellers G; Lönnqvist F
J Lipid Res; 1997 Apr; 38(4):795-804. PubMed ID: 9144094
[TBL] [Abstract][Full Text] [Related]
22. Effects of cortisol and growth hormone on lipolysis in human adipose tissue.
Ottosson M; Lönnroth P; Björntorp P; Edén S
J Clin Endocrinol Metab; 2000 Feb; 85(2):799-803. PubMed ID: 10690893
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms behind lipolytic catecholamine resistance of subcutaneous fat cells in the polycystic ovarian syndrome.
Faulds G; Rydén M; Ek I; Wahrenberg H; Arner P
J Clin Endocrinol Metab; 2003 May; 88(5):2269-73. PubMed ID: 12727985
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide production from rat adipocytes is modulated by beta3-adrenergic receptor agonists and is involved in a cyclic AMP-dependent lipolysis in adipocytes.
Canová NK; Lincová D; Kmonícková E; Kameníková L; Farghali H
Nitric Oxide; 2006 May; 14(3):200-11. PubMed ID: 16413212
[TBL] [Abstract][Full Text] [Related]
25. Multiple lipolysis defects in the insulin resistance (metabolic) syndrome.
Reynisdottir S; Ellerfeldt K; Wahrenberg H; Lithell H; Arner P
J Clin Invest; 1994 Jun; 93(6):2590-9. PubMed ID: 8200997
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms underlying regional differences in lipolysis in human adipose tissue.
Wahrenberg H; Lönnqvist F; Arner P
J Clin Invest; 1989 Aug; 84(2):458-67. PubMed ID: 2503539
[TBL] [Abstract][Full Text] [Related]
27. Catecholamine-induced lipolysis in adipose tissue of the elderly.
Lönnqvist F; Nyberg B; Wahrenberg H; Arner P
J Clin Invest; 1990 May; 85(5):1614-21. PubMed ID: 2159025
[TBL] [Abstract][Full Text] [Related]
28. Effects of weight reduction on the regulation of lipolysis in adipocytes of women with upper-body obesity.
Reynisdottir S; Langin D; Carlström K; Holm C; Rössner S; Arner P
Clin Sci (Lond); 1995 Oct; 89(4):421-9. PubMed ID: 7493443
[TBL] [Abstract][Full Text] [Related]
29. Demonstration of an in vivo functional beta 3-adrenoceptor in man.
Enocksson S; Shimizu M; Lönnqvist F; Nordenström J; Arner P
J Clin Invest; 1995 May; 95(5):2239-45. PubMed ID: 7738189
[TBL] [Abstract][Full Text] [Related]
30. Control of lipolysis in intra-abdominal fat cells of nonhuman primates: comparison with humans.
Bousquet-Mélou A; Galitzky J; Lafontan M; Berlan M
J Lipid Res; 1995 Mar; 36(3):451-61. PubMed ID: 7775857
[TBL] [Abstract][Full Text] [Related]
31. Effect of glucocorticosteroid treatment on beta-adrenoceptor subtype function in adipocytes from patients with asthma.
Reynisdottir S; Wahrenberg H; Bylin G; Arner P
Clin Sci (Lond); 1993 Aug; 85(2):237-44. PubMed ID: 8403793
[TBL] [Abstract][Full Text] [Related]
32. In vivo interactions between beta-1 and beta-2 adrenoceptors regulate catecholamine tachyphylaxia in human adipose tissue.
Arner P; Kriegholm E; Engfeldt P
J Pharmacol Exp Ther; 1991 Oct; 259(1):317-22. PubMed ID: 1681086
[TBL] [Abstract][Full Text] [Related]
33. Is visceral adiposity a significant correlate of subcutaneous adipose cell lipolysis in men?
Mauriège P; Brochu M; Prud'homme D; Tremblay A; Nadeau A; Lemieux S; Després JP
J Clin Endocrinol Metab; 1999 Feb; 84(2):736-42. PubMed ID: 10022446
[TBL] [Abstract][Full Text] [Related]
34. The atrial natriuretic peptide- and catecholamine-induced lipolysis and expression of related genes in adipose tissue in hypothyroid and hyperthyroid patients.
Polak J; Moro C; Klimcakova E; Kovacikova M; Bajzova M; Vitkova M; Kovacova Z; Sotornik R; Berlan M; Viguerie N; Langin D; Stich V
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E246-51. PubMed ID: 17389707
[TBL] [Abstract][Full Text] [Related]
35. Influence of androgenic status on the alpha 2/beta-adrenergic control of lipolysis in white fat cells: predominant alpha 2-antilipolytic response in testosterone-treated-castrated hamsters.
Pecquery R; Leneveu MC; Giudicelli Y
Endocrinology; 1988 Jun; 122(6):2590-6. PubMed ID: 2453344
[TBL] [Abstract][Full Text] [Related]
36. Alpha 2- and beta-adrenergic receptor binding and action in gluteal adipocytes from patients with hypothyroidism and hyperthyroidism.
Richelsen B; Sørensen NS
Metabolism; 1987 Nov; 36(11):1031-9. PubMed ID: 2823049
[TBL] [Abstract][Full Text] [Related]
37. Desensitization of beta-adrenergic responses in adipocytes involves receptor subtypes and cAMP phosphodiesterase.
Bousquet-Mélou A; Galitzky J; Moreno CM; Berlan M; Lafontan M
Eur J Pharmacol; 1995 Apr; 289(2):235-47. PubMed ID: 7621897
[TBL] [Abstract][Full Text] [Related]
38. Growth hormone treatment of hypophysectomized rats increases catecholamine-induced lipolysis and the number of beta-adrenergic receptors in adipocytes: no differences in the effects of growth hormone on different fat depots.
Yang S; Björntorp P; Liu X; Edén S
Obes Res; 1996 Sep; 4(5):471-8. PubMed ID: 8885212
[TBL] [Abstract][Full Text] [Related]
39. A common hormone-sensitive lipase i6 gene polymorphism is associated with decreased human adipocyte lipolytic function.
Hoffstedt J; Arner P; Schalling M; Pedersen NL; Sengul S; Ahlberg S; Iliadou A; Lavebratt C
Diabetes; 2001 Oct; 50(10):2410-3. PubMed ID: 11574428
[TBL] [Abstract][Full Text] [Related]
40. The Arg 389 Gly beta1-adrenergic receptor gene polymorphism and human fat cell lipolysis.
Rydén M; Hoffstedt J; Eriksson P; Bringman S; Arner P
Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1599-603. PubMed ID: 11753577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
